Tokyo

London

New York

Register

Sign In

EUR/USD

1.0851

-0.0031

-0.28%

GBP/USD

1.2796

-0.0017

-0.14%

USD/JPY

110.12

0.0840

0.08%

USD/CHF

0.9970

0.0051

0.51%

EUR/GBP

0.8481

-0.0012

-0.15%

USD/CAD

1.3475

-0.0007

-0.05%

NZD/USD

0.7035

-0.0005

-0.07%

EUR/JPY

119.49

-0.2450

-0.20%

EUR/CHF

1.0818

0.0025

0.23%

Aevi Genomic Medicine

NASDAQ: GNMXHealthcare / Biotechnology / USA
1.54-0.32-17.20%Vol 1 963 8211Y Perf -69.98%
Apr 21st, 2017 16:00
BID1.54 ASK1.57
Open1.78 Previous Close1.86
Pre-Market- After-Trading-
 - -%  - -%
Target Price
7.10 
Analyst Rating
Moderate Buy 1.75
Potencial %
361.04 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
—    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
—    -
Market Cap (mil)69 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
0.74 
Earnings Date
9th May 2017

Today's Price Range

1.501.78

 

52wk Range

1.506.89

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-62.53%
3 Months
-67.64%
6 Months
-67.58%
1 Year
-69.98%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
GNMX1.54-0.3200-17.20
AAPL142.26-0.1800-0.13
GOOG843.191.54000.18
MSFT66.420.92001.40
XOM80.69-0.3200-0.40
WFC53.00-0.5000-0.93
JNJ121.76-0.1100-0.09
FB143.68-0.1200-0.08
GE29.55-0.7200-2.38
JPM84.52-1.0300-1.20
...

TickerPriceChg.%52 Week High
COL104.705.13104.76
SWK137.563.65137.90
RHI47.182.7750.98
HON127.082.67128.30
CSX50.772.4451.28
TSO77.891.9693.06
VLO65.231.7671.40
AWK80.511.6985.24
NEE133.021.64134.33
TXT46.661.6350.93
XEC118.631.45146.96
MSFT66.421.4066.70
NEM34.131.3746.07
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 7.10
Current Ratio 7.20
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -2 093.40
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.88
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -2.80
Cash Flow Per Share -0.93
Price to Tangible Book1.88
Book Value per Share0.94
Enterprise Value (in ths.)25 846
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-109.33
ROE last 12 Months -98.22
Return on Assets (5Y Avg) -55.05
ROA last 12 Months -88.39
Return on Capital (5Y Avg) -194.61
ROC last 12 Months -98.24
Return on invested Capital Q -21.82
Return on invested Capital Y-21.82
Assets Turnover-
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)-
Revenue per Share -
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
3/2017 QR-0.2727.03Positive
6/2017 QR-0.2732.50Positive
12/2017 FY-1.1514.81Positive
12/2018 FY-1.41-7.63Negative
Next Report Date9th May 2017
Estimated EPS Next Report-0.27
Estimates Count3
EPS Growth Next 5 Years %0.00
Volume Overview
Volume1 963 821
Shares Outstanding (in ths.)37 110
Trades Count3 005
Dollar Volume3 011 586
Avg. Volume687 555
Avg. Weekly Volume804 937
Avg. Monthly Volume748 239
Avg. Quarterly Volume795 693

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
2 (50.00 %)
3 (100.00 %)
Moderate Buy
1 (25.00 %)
1 (25.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
1 (25.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.75
Moderate Buy
1.75
Strong Buy
1.00

There are no comments yet.

News

Plus500
x